CSIMarket
 


Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

LH's EPS from Cont. Operations Growth by Quarter and Year

Laboratory Of America Holdings's EPS from Cont. Operations results by quarter and year




LH EPS from Cont. Operations (in $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -6.08 -7.13 1.77
III Quarter September 7.22 2.26 3.14 1.84
II Quarter June 2.38 1.94 2.29 1.87
I Quarter March -3.27 1.88 1.70 1.74
FY   6.33 -0.00 0.00 7.22



LH EPS from Cont. Operations third quarter 2020 Y/Y Growth Comment
Laboratory Corporation Of America Holdings reported EPS from Cont. Operations surge of 219.47% year on year in the third quarter, to $ 7.22 , this is lower than Laboratory Corporation Of America Holdings's recent average EPS from Cont. Operations surge of 281.67%.

According to the results reported in the third quarter, Laboratory Corporation Of America Holdings achieved the best EPS from Cont. Operations growth in Medical Laboratories industry. While Laboratory Corporation Of America Holdings' s EPS from Cont. Operations doubling of 219.47% ranks overall at the positon no. 154 in the third quarter.




LH EPS from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -8.76 %
III Quarter September 219.47 % -28.03 % 70.65 % 16.46 %
II Quarter June 22.68 % -15.28 % 22.46 % 23.84 %
I Quarter March - 10.59 % -2.3 % 4.19 %
FY   - - -100 % 7.76 %

Financial Statements
Laboratory Of America Holdings's third quarter 2020 EPS from Cont. Operations $ 7.22 LH's Income Statement
Laboratory Of America Holdings's third quarter 2019 EPS from Cont. Operations $ 2.26 Quarterly LH's Income Statement
New: More LH's historic EPS from Cont. Operations Growth >>


LH EPS from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -3.8 %
III Quarter September 203.36 % 16.49 % 37.12 % -1.6 %
II Quarter June - 3.19 % 34.71 % 7.47 %
I Quarter March - - -3.95 % -10.31 %
FY (Year on Year)   - - -100 % 7.76 %




EPS from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #20
Overall #154

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
15700 % 281.67 % -99.25 %
(Mar 31 2016)   (Mar 31 2015)
EPS from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #20
Overall #154
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
15700 % 281.67 % -99.25 %
(Mar 31 2016)   (Mar 31 2015)

EPS from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Laboratory Of America Holdings's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
16600 % 302.24 % -99.29 %
(Jun 30 2015)  


LH's III. Quarter Q/Q EPS from Cont. Operations Comment
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2020 below company average EPS from Cont. Operations doubling of 203.36% quarter on quarter, to $ 7.22 .

Even if the III. Quarter 2020 Laboratory Of America Holdings's EPS from Cont. Operations Q/Q growth was beneath the average , it was yet good sign, as the III. Quarter improvement, outshines the 16.49% EPS from Cont. Operations growth in the III. Quarter 2019

Within Medical Laboratories industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Laboratory Of America Holdings's EPS from Cont. Operations growth quarter on quarter, overall rank is 73.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #8
Overall #73
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #8
Overall #73
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
16600 % 302.24 % -99.29 %
(Jun 30 2015)  


LH's III. Quarter Q/Q EPS from Cont. Operations Comment
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2020 below company average EPS from Cont. Operations doubling of 203.36% quarter on quarter, to $ 7.22 .

Albeit the III. Quarter 2020 LH's EPS from Cont. Operations sequential growth was below the regular , it has been yet encouraging sign, as the III. Quarter expension, eclipses the 16.49% EPS from Cont. Operations surge in the same quarter a year ago

Within Medical Laboratories industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Laboratory Of America Holdings's EPS from Cont. Operations growth quarter on quarter, overall rank is 73.


Laboratory Of America Holdings's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative EPS from Cont. Operations 12 Months Ending $ 0.25 $ -4.71 $ -5.15 $ -0.00 $ -1.05
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Laboratory Of America Holdings saw improvement in EPS from Cont. Operations growth trend, posting cumulative 12 months EPS from Cont. Operations growth of 219.47% year on year, to $ 0 if the fiscal year would have ended in Sep 30 2020.
Laboratory Of America Holdings's trailing twelve months EPS from Cont. Operations growth was higher than company's average 5.96% and higher than % growth in Jun 30 2020. And, Laboratory Of America Holdings realized the fastest EPS from Cont. Operations growth, in Medical Laboratories industry. In the Sep 30 2020 period, Laboratory Of America Holdings had cumulative twelve months EPS from Cont. Operations of $ 0 compare to EPS loss from Cont. Operations of $ -1 a year ago.

Laboratory Corporation Of America Holdings achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
4.0532396646335E+16 %
7.7946916627567E+14 %
-100 %
(Mar 31 2019)  

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall # 0

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
55 %
5.96 %
-100 %
(Mar 31 2017)  


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative EPS from Cont. Operations growth Comment
Laboratory Of America Holdings saw improvement in EPS from Cont. Operations growth trend, posting cumulative 12 months EPS from Cont. Operations growth of 219.47% year on year, to $ 0 if the fiscal year would have ended in Sep 30 2020.
Laboratory Of America Holdings's trailing twelve months EPS from Cont. Operations growth was higher than company's average 5.96% and higher than % growth in Jun 30 2020. And, Laboratory Of America Holdings realized the fastest EPS from Cont. Operations growth, in Medical Laboratories industry. In the Sep 30 2020 period, Laboratory Of America Holdings had cumulative twelve months EPS from Cont. Operations of $ 0 compare to EPS loss from Cont. Operations of $ -1 a year ago.

Laboratory Corporation Of America Holdings achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
4.0532396646335E+16 %
7.7946916627567E+14 %
-100 %
(Mar 31 2019)  


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall # 0

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
55 %
5.96 %
-100 %
(Mar 31 2017)  


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0




Other EPS from Cont. Operations Growth
Medical Laboratories Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
LH's EPS from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for LH's Competitors
EPS from Cont. Operations Growth for Laboratory Of America Holdings's Suppliers
EPS from Cont. Operations Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar EPS from Cont. Operations doubling for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2020
Abiomed Inc   375.86 %$ 375.862 
Novocure Limited  350.00 %$ 350.000 
Apollo Medical Holdings Inc   318.18 %$ 318.182 
Integrated Biopharma Inc  300.00 %$ 300.000 
Catalyst Pharmaceuticals Inc   223.08 %$ 223.077 
Laboratory Corporation Of America Holdings  219.47 %$ 219.469 
Procyon Corp  200.00 %$ 200.000 
Antares Pharma Inc   200.00 %$ 200.000 
The Pennant Group Inc   166.67 %$ 166.667 
Amphastar Pharmaceuticals Inc   166.67 %$ 166.667 
Quest Diagnostics Inc  164.15 %$ 164.151 
Universal Health Services Inc  158.18 %$ 158.182 
Infusystem Holdings Inc  150.00 %$ 150.000 
Luna Innovations Inc  150.00 %$ 150.000 
Select Medical Holdings Corp  147.83 %$ 147.826 
Bio techne Corp  128.95 %$ 128.947 
Inspyr Therapeutics Inc   128.57 %$ 128.571 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WIZD's Profile

Stock Price

WIZD's Financials

Business Description

Fundamentals

Charts & Quotes

WIZD's News

Suppliers

WIZD's Competitors

Customers & Markets

Economic Indicators

WIZD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071